Your Notifications
All done, no notifications
Dr. Michal Sarfaty

Dr. Michal Sarfaty

Medical Oncologist

, Ramat Gan, Israel

11 Years of experience

Speaks: Hebrew , English

USD 3000 USD 2800 for video consultation

Chat
Book Video Consultation

About Dr. Michal Sarfaty

  • Dr. Michal Sarfaty is a board-certified clinical oncologist who specialises in tumor diseases of the urinary tract and genital systems, such as prostate, bladder, kidney, penile, and testicular cancer.
  • Her duties also cover management of the Stage I oncology exams on behalf of the Israel Medicine Association.
  • Her primary research areas are innovative bladder, prostate, kidney, and testicular cancer treatments and health economics in oncology medication therapy.
  • Dr. Sarfaty has authored over 30 major publications, including the Journal of Clinical Oncology, European Urology, Annals of Oncology, and The Oncologist.
  • She is also a leader in translational and clinical oncology research.

Conditions treated by Dr. Michal Sarfaty

  • Prostate cancer
  • Bladder cancer
  • Kidney cancer
  • Penile cancer
  • Testicular cancer

Area of Interest

  • Surgical Oncology

Qualification

  • Medical Studies MD, Faculty of Medicine, Tel Aviv University (2003-2011)

Work Experiences

  • Super Specialty in Genitourinary Tumors, Memorial Sloan Kettering Cancer Center, New York (2019-2021)
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Michal Sarfaty on our platform

Consult Online

CERTIFICATIONS (2)

  • Certified Clinical Oncologist
  • Certified Genitourinary Oncologist

RESEARCH PAPERS AND PUBLICATIONS (4)

  • Mutai R, Barkan T, Moore A, Sarfaty M, Shochat T, Yerushalmi R, Stemmer SM, Goldvaser H. Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer. The Breast. 2021 Dec 1;60:62-9.
  • Guercio BJ, Sarfaty M, Teo MY, Ratna N, Duzgol C, Funt SA, Lee CH, Aggen DH, Regazzi AM, Chen Z, Lattanzi M. Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: a real-world experience. Clinical Cancer Research. 2023 Nov 14;29(22):4586-95.
  • Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, Issachar A, Mor E, Sarfaty M, Bragilovski D, Hur RB. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma. Radiation Oncology. 2017 Dec;12:1-8.
  • Sarfaty M, Hall PS, Chan KK, Virik K, Leshno M, Gordon N, Moore A, Neiman V, Rosenbaum E, Goldstein DA. Cost-effectiveness of pembrolizumab in second-line advanced bladder cancer. European Urology. 2018 Jul 1;74(1):57-62.

Share Your Experience about Dr. Michal Sarfaty

Write Your Review

PROCEDURES

  • Adrenal Cancer Treatment
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Head & Neck Cancer Treatment
  • HIPEC
  • Lumpectomy
  • Malignant Mesothelioma Treatment
  • Nasopharyngeal Cancer Treatment
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • Prostatectomy
  • Rhabdomyosarcoma (RMS) Treatment
  • Small Intestine Cancer Treatment
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment

FREQUENTLY ASKED QUESTIONS

Is Doctor Michal Sarfaty doing teleconsultation on the MediGence platform?

Dr. Michal Sarfaty is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation can last from 15 to 30 minutes. Depending on the patient’s queries and the doctor's medical suggestions, it may exceed the estimated time.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I book my procedure with the doctor post-consultation?

Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Can we get an estimate for the procedure?

Yes. Our case manager will provide the cost estimate, including the doctor’s opinion, the cost estimate, and crucial information about traveling to your medical destination.

FAQ's Related to Surgical Oncologist

What does a surgical oncologist do?

A surgical oncologist is a cancer specialist who employs surgery to stage, diagnose, and treat the disease. While their primary role is to excise tumors or affected tissue, they also collaborate with medical and radiation oncologists to coordinate overall cancer therapy.

When should you go to see a surgical oncologist?

After a diagnosis of cancer, surgery may be included in your treatment.

  • A tumor or lump has been found and needs to be removed or biopsied.
  • You desire a second opinion for your cancer surgery options.
  • Because of your suspicious results and high-risk category (such as extensive family history),
  • You've already undergone cancer treatments, and it is recommended that you undergo further surgery or have any remaining tissue removed.
What are the tests required before and during consultation by a surgical oncologist?

The tests required before and during the consultation by a surgical oncologist include:

  • Biopsy
  • Imaging Tests
  • Cancer Screening
  • Laboratory Tests
  • Physical Exam

Most cancer patients undergo a biopsy to remove a sample of tissues from a body part for examination by a pathologist so that cancer can be diagnosed.

Reviewer

Dr. Abdullah Rahil
Dr. Abdullah Rahil

MPT (Neuro)

7 Years of Experience

Dr. Abdullah Rahil, M.P.T. (Neurology), is a dedicated physiotherapy professional specializing in orthopedic, neurological, and musculoskeletal rehabilitation. With strong clinical expertise, he focuses on improving patient mobility, reducing pain, and restoring functional independence through evidence-based rehabilitation techniques. He is skilled in advanced therapeutic approaches that support effective rehabilitation and recovery for a wide range of musculoskeletal and neurological conditions, focusing on improving mobility, reducing pain, and restoring functional independence. Dr. Rahil has extensive experience managing diverse rehabilitation cases. His patient-centered approach emphasizes personalized treatment plans, continuous assessment, and comprehensive rehabilitation to achieve optimal recovery outcomes. View More

Last Reviewed - January 2026

Author

Alvina Hasan
Alvina Hasan

M.Pharm

2 Year of Experience

Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.

With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.

Readers can explore her published research and articles here:

https://carcinogenesis.com/index.php/JOC/article/view/868

https://carcinogenesis.com/index.php/JOC/article/view/870

. View More